Bonura F, Di Lisi D, Novo S, D’Alessandro N (2012 Jun) Timely recognition of cardiovascular toxicity by anticancer agents: a common objective of the pharmacologist, oncologist and cardiologist. Cardiovasc Toxicol 12(2):93–107

Farmakis D, Mantzourani M, Filippatos G (2018) Anthracycline-induced cardiomyopathy: secrets and lies. Eur J Heart Fail 20:907–909

Article  PubMed  Google Scholar 

Curigliano G, Lenihan D, Fradley M, Ganatra S, Barac A, Blaes A et al (2020) Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations. Ann Oncol 31:171–190

Article  CAS  PubMed  Google Scholar 

Zamorano JL, Lancellotti P, Rodriguez Munoz D, Aboyans V, Asteggiano R, Galderisi M et al (2017) ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: the Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur J Heart Fail 19:9–42

Article  PubMed  Google Scholar 

Celutkiene J, Pudil R, Lopez-Fernandez T, Grapsa J, Nihoyannopoulos P, Bergler-Kleinet J et al (2020) Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the heart failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology. Eur J Heart Fail 22:1504–1524

Article  CAS  PubMed  Google Scholar 

Pudil R, Mueller C, Celutkiene J, Henriksen PA, Lenihan D, Dent S (2020) Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the heart failure Association and the Cardio-Oncology Council of the European Society of Cardiology. Eur J Heart Fail 22:1966–1983

Article  CAS  PubMed  Google Scholar 

Di Lisi D, Madaudo C, Alagna G, Santoro M, Rossetto L, Siragusa S (2022) The new HFA/ICOS risk assessment tool to identify patients with chronic myeloid leukaemia at high risk of cardiotoxicity. ESC Heart Fail 31. https://doi.org/10.1002/ehf2.13897

Thavendiranathan P, Poulin F, Lim KD, Plana JC, Woo A, Marwick TH (2014) Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review. J Am Coll Cardiol 63:2751–2768

Article  PubMed  Google Scholar 

Ilardi F, D’Andrea A, D’Ascenzi F, Bandera F, Benfari G, Esposito R et al (2021) Myocardial work by Echocardiography: principles and applications in clinical practice. J Clin Med 10(19):4521

Article  PubMed  PubMed Central  Google Scholar 

Di Lisi D, Manno G, Novo G (2021) Subclinical cardiotoxicity: the emerging role of myocardial work and other Imaging techniques. Curr Probl Cardiol 46(6):100818

Article  PubMed  Google Scholar 

Lyon AR, Dent S, Stanway S, Earl H, Brezden-Masley C, Cohen-Solal A et al (2020 Nov) Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the heart failure association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society. Eur J Heart Fail 22(11):1945–1960

Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28:1–39e14

Article  PubMed  Google Scholar 

Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen T, Flachskampf FA, Gillebert TC, Klein AL, Lancellotti P, Marino P, Oh JK, Popescu BA, Waggoner AD (2016) Recommendations for the evaluation of left ventricular diastolic function by Echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 17(12):1321–1360

Article  PubMed  Google Scholar 

Manganaro R, Marchetta S, Dulgheru R, Ilardi F, Sugimoto T, Robinet S et al (2019) Echocardiographic reference ranges for normal non-invasive myocardial work indices: results from the EACVI NORRE study. Eur Heart J Cardiovasc Imaging 20(5):582–590

Article  PubMed  Google Scholar 

Poterucha JT, Kutty S, Lindquist RK, Li L, Eidem BW (2012) Changes in left ventricular longitudinal strain with anthracycline chemotherapy in adolescents precede subsequent decreased left ventricular ejection fraction. J Am Soc Echocardiogr 25:733–740

Article  PubMed  Google Scholar 

Arciniegas Calle MC, Sandhu NP, Xia H, Cha SS, Pellikka PA, Ye Z, Herrmann J, Villarraga HR (2018) Two-dimensional speckle tracking echocardiography predicts early subclinical cardiotoxicity associated with anthracycline-trastuzumab chemotherapy in patients with breast cancer. BMC Cancer 18(1):1037

Article  PubMed  PubMed Central  Google Scholar 

Plana JC, Galderisi M, Barac A, Ewer MS, Ky B, Scherrer-Crosbie M et al (2014) Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J – Cardiovasc Imaging 15:1063–1093

Article  PubMed  PubMed Central  Google Scholar 

Stanton T, Leano R, Marwick TH (2009) Prediction of all-cause mortality from global longitudinal speckle strain: comparison with ejection fraction and wall motion scoring. Circ Cardiovasc Imaging 2:356–364

Article  PubMed  Google Scholar 

Cho GY, Marwick TH, Kim HS, Kim MK, Hong KS, Oh DJ (2009) Global 2-dimensional strain as a new prognosticator in patients with heart failure. J Am Coll Cardiol 54:618–624

Article  PubMed  Google Scholar 

Janwanishstaporn S, Cho JY, Feng S, Brann A, Seo JS, Narezkina A, Greenberg B (2022) Prognostic value of global longitudinal strain in patients with heart failure with improved ejection fraction. JACC Heart Fail 10(1):27–37

Article  PubMed  Google Scholar 

Jung IH, Park JH, Lee JA, Kim GS, Lee HY, Byun YS, Kim BO (2020) Left ventricular global longitudinal strain as a predictor for Left Ventricular Reverse Remodeling in Dilated Cardiomyopathy. J Cardiovasc Imaging 28(2):137–149

Article  PubMed  PubMed Central  Google Scholar 

Yingchoncharoen T, Agarwal S, Popović Z, Marwick T (2013) Normal ranges of left ventricular strain: a Meta-analysis. J Am Soc Echocardiogr 26:185–191

Article  PubMed  Google Scholar 

Kosmala W, Negishi T, Thavendiranathan P, Penicka M, De Blois J, Murbræch K Incremental Value of Myocardial Work over Global Longitudinal Strain in the Surveillance for Cancer-Treatment-Related Cardiac Dysfunction: A Case-Control Study. J Clin Med. Feb 9;11(4):912.

Clemmensen TS, Eiskjær H, Ladefoged B, Mikkelsen F, Sørensen J, Granstam SO et al (2022) Prognostic implications of left ventricular myocardial work indices in cardiac amyloidosis. European Heart Journal - Cardiovascular Imaging 2021; 22: 695–704.

Ruizhong L, Yanhong L, Fei W, Yushi W, Yuqiong L (2021) The role of myocardial work in evaluating coronary microcirculation of STEMI patients after percutaneous coronary intervention. Echocardiography 38(12):2060–2068

Article  PubMed  Google Scholar 

Hiemstra YL, van der Bijl P, el Mahdiui M, Bax JJ, Delgado V, Marsan NA (2020) Myocardial work in nonobstructive hypertrophic cardiomyopathy: implications for Outcome. J Am Soc Echocardiogr 33:1201–1208

Article  PubMed  Google Scholar 

Galli E, Vitel E, Schnell F, Le Rolle V, Hubert A, Lederlin M, Donal E (2019) Myocardial constructive work is impaired in hypertrophic cardiomyopathy and predicts left ventricular fibrosis. Echocardiography 36:74–82

Article  PubMed  Google Scholar 

Bouali Y, Donal E, Gallard A, Laurin C, Hubert A, Bidaut A, Leclercq C, Galli E (2020) Prognostic usefulness of myocardial work in patients with heart failure and reduced ejection fraction treated by Sacubitril/Valsartan. Am J Cardiol 125:1856–1862

Article  CAS  PubMed  Google Scholar 

Galli E, Leclercq C, Fournet M et al (2018) Value of myocardial work estimation in the prediction of response to cardiac resynchronization therapy. J Am Soc Echocardiogr 31:220–230

Article  PubMed  Google Scholar 

Lyon AR, López-Fernández T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J (2022) 2022 ESC Guidelines on cardio-oncology developed in collaboration with the european Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J Cardiovasc Imaging 23(10):e333–e465

Article  PubMed  Google Scholar 

Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M et al (2022 Feb) 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur J Prev Cardiol 19(1):5–115

Mercurio V, Cuomo A, Cadeddu Dessalvi C, Deidda M, Di Lisi D, Novo G (2020) RedoxImbalancesinAgeingandMetabolicAlterations:ImplicationsinCancerandCardiacDiseases.AnOverviewfromtheWorkingGroupofCardiotoxicityandCardioprotectionoftheItalianSocietyofCardiology(SIC).Antioxidants(Basel).Jul21;9(7):641